1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62
The American Journal of Pathology, Vol. 184, No. 12, December 2014
ajp.amjpathol.org
b-Catenin Links Hepatic Metabolic Zonation with Lipid Metabolism and Diet-Induced Obesity in Mice Q18
Jaideep Behari,* Huanan Li,* Shiguang Liu,* Maja Stefanovic-Racic,y Laura Alonso,y Christopher P. O’Donnell,z Sruti Shiva,x Srikanth Singamsetty,z Yoshio Watanabe,z Vijay P. Singh,* and Qing Liu* From the Divisions of Gastroenterology, Hepatology, and Nutrition,* Endocrinology and Metabolism,y and Pulmonary and Critical Care Medicine,z Department of Medicine, and the Department of Pharmacology and Chemical Biology,x University of Pittsburgh, Pittsburgh, Pennsylvania Accepted for publication August 21, 2014. Address correspondence to Jaideep Behari, M.D., Ph.D., Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Ste. 916, Kaufmann Medical Bldg., 3471 Fifth Ave., Pittsburgh, PA 15213. E-mail: [email protected].
Q1
b-catenin regulates the establishment of hepatic metabolic zonation. To elucidate the functional significance of liver metabolic zonation in the chronically overfed state in vivo, we fed a high-fat diet (HFD) to hepatocyte-specific b-catenin transgenic (TG) and knockout (KO) mice. Chow-fed TG and KO mice had normal liver histologic findings and body weight. However, HFD-fed TG mice developed prominent perivenous steatosis with periportal sparing. In contrast, HFD-fed KO mice had increased lobular inflammation and hepatocyte apoptosis. HFD-fed TG mice rapidly developed diet-induced obesity and systemic insulin resistance, but KO mice were resistant to diet-induced obesity. However, b-catenin did not directly affect hepatic insulin signaling, suggesting that the metabolic effects of b-catenin occurred via a parallel pathway. Hepatic expression of key glycolytic and lipogenic genes was higher in HFD-fed TG and lower in KO mice compared with wild-type mice. KO mice also exhibited defective hepatic fatty acid oxidation and fasting ketogenesis. Hepatic levels of hypoxia inducible factor-1a, an oxygen-sensitive transcriptional regulator of glycolysis and a known b-catenin binding partner, were higher in HFD-fed TG and lower in KO mice. KO mice had attenuated perivenous hypoxia, suggesting disruption of the normal sinusoidal oxygen gradient, a major determinant of liver carbohydrate and liver metabolism. Canonical Wnt signaling in hepatocytes is essential for the development of diet-induced fatty liver and obesity. (Am J Pathol 2014, 184: 1e15; http://dx.doi.org/10.1016/j.ajpath.2014.08.022)
The liver exhibits remarkable metabolic plasticity that allows it to play a central role in systemic energy homeostasis. During periods of starvation, the liver is a major source of energy via hepatic glucose and ketone body production. In contrast, after feeding, the liver suppresses glucose production, takes up glucose, up-regulates lipogenesis, and helps to restore normoglycemia.1 Dysfunction of these normal physiologic processes plays a role in the pathogenesis of major metabolic disorders, such as obesity, diabetes mellitus, and nonalcoholic fatty liver disease (NAFLD). Thus, it is critical to elucidate the molecular pathways that regulate normal liver metabolic function. The mammalian liver exhibits metabolic zonation, which is characterized by the heterogeneous distribution of metabolic function across the hepatic lobule.2 Functions such as oxidative phosphorylation and gluconeogenesis predominate in the periportal (zone 1) region. In contrast, glycolysis, lipogenesis, and xenobiotic metabolism occur predominantly
in the perivenous (zone 3) region.2,3 Most metabolic functions exhibit dynamic zonation, depending on the prevailing nutritional state. In contrast, some functions (eg, expression of glutamine synthetase [GS] in a narrow rim of perivenous hepatocytes) exhibit fixed zonation that does not vary with the feeding cycle. b-catenin, the central player in the canonical Wnt signaling pathway, plays a critical role in establishing liver metabolic zonation. Targeted deletion of b-catenin in hepatocytes causes expansion of the periportal gene expression program and down-regulation of many perivenous genes. Conversely, constitutive activation of b-catenin expands the perivenous Supported in part by NIH grant 5K08AA017622 (J.B.). Disclosures: None declared. Current address of L.A., Division of Diabetes, Department of Medicine, University of Massachusetts Medical School, Worcester, MA; of V.P.S., Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ.
Copyright ª 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/j.ajpath.2014.08.022
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124
125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186
Behari et al gene expression program and down-regulates expression of periportal genes.4 Currently, we do not understand the precise role of metabolic zonation in liver and systemic carbohydrate and lipid metabolism in vivo. We used liver-specific b-catenin knockout (KO) and transgenic (TG) mice to determine the effect of manipulating liver metabolic zonation in the chronically overfed state. We found that by linking metabolic zonation with lipogenesis and systemic energy balance, b-catenin, plays a critical role in conferring metabolic plasticity to the liver.
Materials and Methods Animals and Dietary Treatments
Q2
Liver-specific b-catenin KO mice (Ctnnb1loxp/loxp;AlbuminCreþ/) in a C57Bl/6 background were generated as previously described.5 Littermates with wild-type Ctnnb1 allele were used as controls. Liver-specific b-catenin TG mice were a gift of Dr. Satdarshan Monga (University of Pittsburgh, Pittsburgh, PA) and were generated as previously described.6 TG mice express, under control of the hepatocyte-specific albumin promoter, b-catenin protein carrying a mutation (S45D) that makes it resistant to proteasomal degradation. TG mice were generated in a mixed background and backcrossed for six generations into the C57BL/6 background. Male mice between 8 and 12 weeks of age were used for all experiments. The animals were maintained under a 12hour dark/light cycle and had free access to food and water. An adjusted calorie high-fat diet (HFD; Harlan Teklad TD.88137, Harlan Laboratories, Indianapolis, IN; 4.5 kcal/ g with 15.2% kcal from protein, 42.7% kcal from carbohydrate, and 42% kcal from fat) or chow diet (Teklad Global Diet 2018, Harlan Laboratories; 3.1 kcal/g with 24% kcal from protein, 58% kcal from carbohydrate, and 18% kcal from fat) was used for 1 to 8 weeks as indicated in the results section. For experiments with HFD and chow-fed mice, animals were fasted for 4 hours before sacrifice. For fastingrefeeding experiments, chow-fed mice were fasted overnight (16 hours) and sacrificed at 7 AM or fasted overnight and then refed for exactly 6 hours and sacrificed at 1 PM. In all experiments and at each time point, the KO or TG mice were paired with corresponding wild-type (WT) animals to allow comparisons among genotypes. All animal experiments were performed with the approval of the University of Pittsburgh Institutional Animal Care and Use Committee and in accordance with NIH guidelines.
Serum and Liver Biochemical Assays Blood glucose was measured using an Ascencia XL Glucometer or a commercially available kit from Stanbio Laboratory (Boerne, TX; catalog no. 1070). Serum insulin was measured by radioimmunoassay (Linco sensitive rat insulin radioimmunoassay kit; Millipore, Billerica, MA). The serum
2
glutamine level was measured by quantitative colorimetric determination via a commercially available assay kit (BioAssay Systems, Hayward, CA; catalog no. EGLN-100). Serum b-hydroxybutyrate levels were measured using an automated analyzer by the University of Pittsburgh Medical Center Clinical Chemistry Laboratory. Serum and liver triglyceride and cholesterol assays were performed as previously described.7,8
Glucose Tolerance Test, Insulin Treatment, and Hyperinsulinemic-Euglycemic Clamp Studies Glucose tolerance test was performed in mice fasted for 16 hours followed by 1-g/kg intraperitoneal glucose injection. Blood glucose was measured from the tail vein at baseline and 15, 30, 60, and 90 minutes using a glucose meter. For treatment with insulin, mice maintained on chow diet were fasted overnight and injected with an i.p. bolus injection of insulin (2 U/kg). Mice were euthanized after 20 minutes and livers rapidly harvested and snap frozen in liquid nitrogen for further analysis. For insulin clamp studies, catheters were chronically implanted in the left femoral artery and vein for measurement of blood glucose and for infusion of insulin and radioisotope tracers. After a 48- to 72-hour recovery period after catheter placement, serum was collected from overnight-fasted mice for measurement of plasma insulin, free fatty acids, and glucose. Baseline hepatic glucose output was determined during a 120-minute period by infusing [3-3H]glucose (10mCi bolus þ 0.1 mCi/minute; NEN Life Science Products, Boston, MA) through the femoral vein using a microdialysis pump. A 100-mL sample of arterial blood was collected at 120 minutes for determination of plasma glucose, insulin, and [3-3H]glucose levels. After the basal period, a 2-hour hyperinsulinemic euglycemic clamp procedure was performed. Whole-body insulin sensitivity was determined by infusing a constant rate of human insulin and a variable rate of dextrose 50% glucose through the femoral venous catheter and maintaining plasma glucose at 100 to 125 mg/dL. Blood glucose levels were sampled from the femoral artery catheter at 10-minute intervals using a glucose meter. The mean glucose infusion rate during the last 30 minutes of the insulin clamp was used to determine insulin sensitivity.
Histologic and IHC Evaluation of the Liver Formalin-fixed, paraffin-embedded liver sections were stained with hematoxylin and eosin (H&E) or Oil Red O as previously described.5 Liver sections were stained with b-catenin (1:200), cytochrome P450 (Cyp) 2E1 (1:100), and GS (1:100) antibodies from Abcam (Cambridge, MA) using standard immunohistochemical (IHC) techniques. Staining for apoptotic cells by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) method was performed using the ApopTag Peroxidase Kit (Millipore; catalog no. S7100). Liver cryosections were stained for glucokinase (GCK; 1:50; Santa
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248
249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310
b-Catenin Links Hepatic Lipid Metabolism Cruz Biotechnology, Santa Cruz, CA) and immunofluorescence microscopy performed as previously described.7
Gene Expression Analysis by Protein Immunoblotting and Real-Time PCR
Q3
Crude liver extracts were prepared as previously described.8 Immunoblotting was performed using the following primary antibodies: b-catenin (BD Biosciences and Cell Signaling, San Jose, CA), glyceraldehyde-3-phosphate dehydrogenase (Abcam), fatty acid synthase (Santa Cruz Biotechnology), GCK (Santa Cruz Biotechnology), hypoxia inducible factor (HIF)-1a (Novus Biologicals, Littleton, CO), phosphor-Akt (Ser473), phosphor-Akt (Thr308), pan-Akt, phosho-S6, S6, phosphor-GSK-3b (Ser9), and GSK-3b (all from Cell Signaling), peroxisome proliferator-activated receptor (PPAR)-g (Santa Cruz), a-tubulin (Abcam), cytochrome c oxidase (COX) IV antibody (Cell Signaling), and peroxisome proliferator-activated receptor gamma coactivator (PGC)-1a (Novus Biologicals). Western blots were quantified using densitometric analysis using the ImageJ version 1.44 (NIH, Bethesda, MD).9 Results from two experiments, each with two samples per group, were averaged and normalized to the corresponding loading control. Real-time PCR was performed using proprietary Taqman primers (Applied Biosystems, Carlsbad, CA) as previously described.8
Metabolic Cage Experiment
Q4
The respiratory exchange ratio, activity, and stool output were measured in an Oxymax Comprehensive Laboratory Animal Monitoring System (Columbus Instruments, Columbus, OH) with 1 mouse per chamber. WT and KO mice were allowed ad libitum access to the HFD for 1 week before the experiment. On day 7, mice were weighed and placed in the chamber at 10 AM and allowed to acclimate for 4 hours. Measurements for oxygen consumption, carbon dioxide consumption, and activity were recorded on a computer every 10 minutes for the next 20 hours at room temperature. The animals had free access to food and water during the experiment. The respiratory exchange ratio was measured as carbon dioxide consumption/ oxygen consumption, and activity was calculated as the sum of x þ z (ambulatory and vertical movements, respectively) scores. Food intake and stool output were measured at the end of the experiment.
ChIP Assay
Q5
Chromatin immunoprecipitation (ChIP) assays were performed using the Millipore ChIP assay kit (catalog no. 17-295) as previously described.7 The human hepatoma cell line Hep3B and transcription factor (TCF)-4 antibody (Millipore; catalog no. 17-10109) were used for the ChIP assay. Positive control primers for the SP5 promoter were as follows: 50 -GGGTCTCCAGGCGGCAAG-30 (forward primer) and 50 -AGCGAAAGCAAATCCTTTGAATCC-30 (reverse primer). Scanning
The American Journal of Pathology
-
ChIP primers were designed at 300- to 400-bp intervals along the liver-specific human Gck promoter. The primers spanned a region from 3000 to þ200 bp relative to the liver-specific transcription start of the Gck promoter. An unrelated promoter (b-actin) was used as the negative control. Scanning primer sequences are available on request.
Hypoxia Studies and Pimonidazole Staining for Tissue Hypoxia Mice were placed in regular cages customized to deliver varying concentrations of inspired oxygen. A gas control delivery system regulated the flow of oxygen, nitrogen, and room air into the customized cages, and a series of flow regulators allowed the manipulation of inspired oxygen.10 In the intermittent hypoxia group, oxygen levels decreased from 21% to 6% for a 30-second period followed by quick reoxygenation to room air levels via a burst of 100% oxygen (60 cycles hour1). A second set of mice was exposed to continuous hypoxia in the customized cages during which the oxygen concentration was maintained at 10%. Control animals (sham treated) were housed in the same customized cages at the same time as the treated animals but only exposed to room air (21% oxygen). The Hypoxyprobe-1 Omni kit (HPI Inc., Burlington, MA) was used for the detection of tissue hypoxia. Pimonidazole hydrochloride was administered by i.p. injection at a dosage of 60 mg/kg. Liver tissue was collected after 60 minutes. Pimonidazole is reductively activated in hypoxic cells, and the activated intermediate forms stable covalent adducts with proteins.11 IHC for protein adducts of pimonidazole was performed with PAb2627AP, an affinity purified rabbit antibody as per the manufacturer’s recommendations (HPI Inc.).
Determination of Mitochondrial Biogenesis Mitochondrial DNA copy number was determined using a modification of a previously described approach.12 Total DNA was prepared from liver tissue using DNeasy spin columns and DNA concentration measured spectrophotometrically. The quantity of mitochondrial-encoded COX1 relative to the nuclear-encoded gene 18S rRNA was measured using TaqMan real-time using proprietary primers (Applied Biosystems; Mm04225243_g1). Mitochondrial aerobic capacity was measured by assaying for the activity of the mitochondrial matrix enzyme citrate synthase activity as previously described.7
Palmitate Oxidation Assays Fatty acid oxidation was determined ex vivo in freshly harvested livers as previously described.13 Liver sections were weighed (approximately 200 mg per well) and incubated in Dulbecco’s modified Eagle’s medium/10% fetal Q6
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
3
311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372
373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 ½F1 396 397 398 Q7 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 ½F2 425 426 427 428 429 430 431 432 433 434
Behari et al bovine serum in the presence of 0.1 mmol/L palmitate and [3H]-palmitate (20 mCi per well) at 37 C for 2 hours in duplicate wells for each animal. Tritiated water was determined in the collected medium by a vapor-phase equilibration method.
Statistical Analysis Results were analyzed by Student’s t-test for comparison between the two groups and by one-way analysis of variance when more than two groups were compared. P < 0.05 was considered significant.
Results Hepatic b-Catenin Determines Zonal Patterns of Liver Steatosis on the HFD On chow diet, TG mice exhibited grossly normal liver but 8% higher liver/body ratio compared with WT mice, as previously described (Figure 1, A and B).6 TG mice also had normal serum biochemical assay results (data not shown). On histologic examination, neither group of mice exhibited liver steatosis on chow diet. However, at 8 weeks on the HFD, TG mice exhibited grossly larger and steatotic livers but similar liver/body ratio to WT mice (Figure 1, A and B). On H&E staining, HFD-fed TG mice had a striking increase in hepatic steatosis in perivenous and midzonal hepatocytes. In contrast to the lipid-laden perivenous hepatocytes, we observed almost no steatosis in periportal hepatocytes in HFD-fed TG mice (Figure 1C). Oil Red O staining revealed a higher amount of neutral lipid in hepatocytes from HFD-fed TG mice (Figure 1C). Hepatocytes in HFD-fed TG mice were larger than in HFD-fed WT mice and engorged with microvesicular and macrovesicular steatosis (Figure 1D). HFD-fed TG mice had threefold higher liver triglyceride levels but similar total cholesterol levels compared with WT mice (Figure 1E). We treated another set of WT and TG mice with chow and HFD for 4 weeks. TG mice fed the HFD for 4 weeks had a phenotype similar to that at 8 weeks, except that weight gain (data not shown) and degree of perivenous steatosis (Supplemental Figure S1) were less striking at 4 weeks than at 8 weeks. KO mice had similar histologic appearance to WT mice on chow diet. However, at 4 weeks, HFD-fed KO mice had more prominent periportal steatosis with relative perivenous sparing (Figure 2A). HFD-fed KO mice also exhibited increased lobular inflammation (Figure 2B). However, WT and KO mice exhibited similar gross appearance of the liver on the HFD (Figure 2C). HFD-fed KO mice had lower hepatic triglyceride levels but similar total cholesterol levels compared with WT mice (Figure 2D). TUNEL staining revealed multiple apoptotic cells in livers from HFD-fed KO mice (Figure 2E and Supplemental Figure S2), and Western blot analysis revealed higher
4
activated caspase 3 levels in livers of HFD-fed KO mice (Figure 2F and Supplemental Figure S3). Thus, KO mice exhibited lower hepatic triglyceride accumulation but higher HFD-induced hepatocyte toxic effects. In HFD-fed TG mice, we found no difference in TUNEL staining or activated caspase 3 level in the liver relative to HFD-fed WT mice (data not shown).
Effect of HFD on b-Catenin and Zonal Expression Patterns of Its Target Genes As expected, hepatocytes were negative for b-catenin staining in KO mice. However, HFD-fed TG mice frequently had cytoplasmic and nuclear staining for b-catenin in hepatocytes (Figure 3 and Supplemental Figure S4). ½F3 Two well-established b-catenin target genes, Cyp2E1 and GS, exhibit differential perivenous expression patterns. Cyp2E1 exhibits dynamic zonation, whereas GS exhibits fixed zonation in a narrow rim of perivenous hepatocytes. We found increased intensity of Cyp2E1 staining and expansion of the perivenous zone of expression in HFD-fed WT mice (Figure 3). We observed no hepatic Cyp2E1 staining in KO mice. In chow-fed TG mice, we found that a wider zone of perivenous hepatocytes stained positive for Cyp2E1. In HFDfed TG mice, Cyp2E1 expression expanded to the midzonal region and strongly correlated with steatosis within hepatocytes (Figure 3). In contrast to Cyp2E1, we found no difference between chow- and HFD-fed WT mice in the zonal pattern of expression of GS. KO mice did not express GS in the liver. TG mice exhibited more intense GS staining but in a zonal expression pattern that was similar to that in WT mice (Figure 3). Consistent with the changes in hepatic GS expression, KO mice exhibited lower and TG mice higher serum glutamine levels on chow and HFD diets compared with WT mice (Supplemental Q8 Figure S5).
Hepatic b-Catenin Modulates Development of Diet-Induced Obesity On chow diet, WT and TG mice had similar weight and were morphologically indistinguishable. However, HFD-fed TG mice gained more weight and at 8 weeks exhibited prominent visceral fat and higher perigonadal fat pad mass compared with WT mice (Figure 4A). On chow diet, KO mice had body ½F4 weight and visceral fat similar to WT mice. However, HFDfed KO mice gained less weight and exhibited less prominent visceral fat and lower perigonadal fat pad mass at 4 weeks compared with WT mice (Figure 4B and Supplemental Figure S6). We next performed metabolic cage experiments with mice fed the HFD for 1 week to acclimatize them to the diet but avoid potential compensatory changes. Compared with WT mice, HFD-fed KO mice exhibited overall higher and TG mice lower respiratory exchange ratio (3%, P < 0.01) (Figure 4C). The three genotypes had similar activity levels
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496
and normal circadian variation in activity (Figure 4D). Food intake was similar between the mice (Figure 4E). HFD-fed KO mice but not TG mice had twofold higher stool mass, suggesting defects in intestinal fat absorption
Q9
(Figure 4F). To ensure that these systemic effects resulted from hepatic b-catenin disruption, we confirmed that bcatenin expression was intact in extrahepatic tissues (Figure 4G).
print & web 4C=FPO
497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558
b-Catenin Links Hepatic Lipid Metabolism
Figure 1 High-fat diet (HFD)efed transgenic (TG) mice have a predominantly perivenous pattern of liver steatosis. Mice were fed the HFD or chow diets for 8 weeks. For tissue collection, mice were fasted for 4 hours from 7 AM and sacrificed at 11 AM. A: Gross appearance of the liver from chow and HFD-fed TG and wild-type (WT) mice. B: Liver/body weight ratio. C: Liver sections stained with hematoxylin-eosin and Oil Red O. Note the strongly perivenous pattern of steatosis with periportal sparing in TG/HFD livers. D: Magnified view of hepatocytes from HFD-fed WT and TG liver. E: Liver triglyceride and total cholesterol levels. Data are expressed as means SEM of five mice per group (chow) and seven mice per group (HFD). *P < 0.05, **P < 0.01. Scale bar Z 100 mm (C). Original magnification: 100 (C, top row); 200 (C, remaining rows, and D). C, central vein; P, portal area.
The American Journal of Pathology
-
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
5
559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 Q12 Q13 615 616 617 618 619 620
b-Catenin Does Not Directly Affect Hepatic Insulin Signaling Random and fasting serum glucose levels were similar in HFD-fed WT and TG mice. In contrast, HFD-fed TG mice
exhibited higher fasting serum insulin levels (Figure 5A). ½F5 TG mice also exhibited impaired glucose tolerance on the HFD but not chow diet (Figure 5B). Similar to previously published results, KO mice exhibited improved insulin sensitivity on both chow and HFD (data not shown).14
print & web 4C=FPO
621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682
Behari et al
Figure 2
High-fat diet (HFD)efed knockout (KO) mice exhibit periportal steatosis, lobular inflammation, and hepatocyte apoptosis. Mice were fed the HFD or chow diets for 4 weeks. Mice were fasted for 4 hours from 7 AM and sacrificed at 11 AM for tissue collection. A: Hematoxylin and eosin (H&E)estained liver sections from chow- or HFD-fed wild-type (WT) and KO mice. B: Low power view of H&E-stained liver sections. Note the foci of inflammatory cells in HFD-fed KO liver. C: Gross liver morphologic findings in mice on chow and HFD diets and quantitation of liver/body ratio. D: Liver triglyceride and total cholesterol levels at 4 weeks. Data are presented as means SEM of five mice per group. E: Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining reveals apoptotic cells in livers from HFD-fed KO mice (black arrowheads). F: Western blot analysis for activated caspase 3 (longer exposure emphasizes differences in C3 expression). Glyceraldehyde-3-phosphate dehydrogenase is the internal loading control (shorter exposure). Scale bar Z 100 mm (A and B). Original magnification: 200 (A); 100 (B); 400 (E). *P < 0.05. Neg, negative control; Pos, positive control (spleen sections).
6
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
Q14
683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744
print & web 4C=FPO
745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806
b-Catenin Links Hepatic Lipid Metabolism
Figure 3 Zonal expression patterns of b-catenin and its target genes on mice fed the high-fat diet (HFD). Mice were fed the HFD or chow diets for 4 weeks. For tissue collection, mice were fasted for 4 hours from 7 AM and sacrificed at 11 AM. A: Liver sections from chow- or HFD-fed knockout (KO), wild-type (WT), and transgenic (TG) mice stained with b-catenin, Cyp2E1, or GS as indicated. Hepatocytes with cytoplasmic and nuclear b-catenin staining on the HFD are marked with white arrowheads. Note the absence of Cyp2E1 and GS staining in KO mice and the perivenous zonal pattern of expression of both genes in WT and TG mice. Also note the correlation between Cyp2E1 staining and hepatocyte steatosis in HFD-fed TG mice.
We next performed hyperinsulinemic-euglycemic clamp studies on long-term catheterized conscious mice to determine the mechanism of HFD-induced insulin resistance. Chow-fed TG and WT mice had similar insulin sensitivity and hepatic glucose production (Figure 5, C and D). These results suggest that insulin resistance in HFD-fed TG mice
The American Journal of Pathology
-
was the result of increased adiposity and fatty liver and not the mutant b-catenin allele per se. To determine the effect of b-catenin on insulin signaling, we treated chow-fed, overnight fasted WT, KO, and TG mice with insulin. In the fasting state or after insulin treatment, we found similar phosphorylation patterns of proteins (Akt, GSK-3b, and
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
7
Q15 Q19
807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868
print & web 4C=FPO
869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930
Behari et al
Hepatic b-catenin regulates systemic energy homeostasis. A: Body weight change, morphologic findings, and perigonadal fat pads from chowand high-fat diet (HFD)efed transgenic (TG) and wild-type (WT) mice. Mice were fed chow or HFD for 8 weeks and fasted for 4 hours before sacrifice for tissue collection at 11 AM. B: Body weight change, morphologic findings, and perigonadal fat pads from chow and HFD-fed WT and knockout (KO) mice. Mice were fed chow or HFD for 4 weeks and fasted for 4 hours before sacrifice for tissue collection at 11 AM. C: Respiratory exchange ratio on the HFD. D: Activity level on the HFD expressed as the total of X (horizontal) and Z (vertical) movements measured in the metabolic cage. E: Food intake in HFD-fed WT, TG, and KO mice measured during the metabolic cage experiment. F: Feces dry weight on the HFD during 24 hours. G: Protein immunoblot analysis for b-catenin using lysates prepared from various organs from WT and KO mice. Glyceraldehyde-3-phosphate dehydrogenase was used as a loading control. n Z 5 to 8 per group (A); n Z 5 to 7 per group (B); n Z 5 per group (CeF). *P < 0.05 (AeD and F). Pancr, pancreas; VAT, visceral adipose tissue; Vastus, vastus muscle.
Figure 4
S6) in the insulin-signaling pathway (Figure 5E). We conclude that b-catenin does not directly affect hepatic insulin signaling.
b-Catenin Regulates Hepatic Fatty Acid Oxidation, Ketogenesis, and Mitochondrial Function In the fasting state, both mitochondrial fatty acid oxidation and ketogenesis predominate in periportal hepatocytes.15
8
We hypothesized that an underlying mitochondrial defect contributes to periportal steatosis in HFD-fed KO mice. We found that chow-fed KO mice had lower hepatic palmitate oxidation rate ex vivo (Figure 6A). Chow-fed ½F6 fasted KO mice also exhibited lower serum levels of the ketone body b-hydroxybutyrate, suggesting defective fasting ketogenesis (Figure 6B). We also found lower mitochondrial activity of citrate synthase, the rate-limiting
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992
993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054
b-Catenin Links Hepatic Lipid Metabolism
b-Catenin Regulates Expression of Glycolytic and Lipogenic Genes on the HFD
b-catenin indirectly regulates hepatic insulin signaling. A: Fasting or random serum glucose from high-fat diet (HFD)efed wild-type (WT) and transgenic (TG) mice and serum insulin levels from chow or HFD-fed WT and TG mice collected after 4 hours of fasting. B: I.P. glucose tolerance tests (GTTs) in chow and HFD-fed WT and TG mice. C: Hyperinsulinemic-euglycemic clamp studies with chow-fed WT and TG mice revealing glucose infusion rate, blood glucose levels during the clamp, and hepatic glucose production. D: Hepatic glucose output measured during the insulin clamp study. E: Western blot analysis for proteins in the insulin-signaling pathway. Chow-fed, 16-hour overnight fasted mice were injected i.p. with saline (minus sign) or insulin (plus sign) and livers were harvested after 20 minutes. n Z 4 to 5 per group (A), n Z 5 per group (BeD). *P < 0.05, ***P < 0.001.
Figure 5
Q16
step in the tricarboxylic acid cycle, in fasted chow-fed KO mice (Figure 6C). Thus, KO mice have defective mitochondrial function in the liver. Wnt signaling regulates mitochondrial biogenesis.16 Therefore, we asked whether changes in b-catenin affected hepatic mitochondrial biogenesis. Mitochondrial DNA content, as measured by the relative DNA amounts of mitochondrialencoded COXI and nuclear-encoded 18S rRNA, was lower in HFD-fed KO and higher in TG mice at 4 weeks (Figure 6D). Immunoblot for COXIV protein revealed higher levels of the protein in chow and HFD-TG mice compared with WT animals, although levels between KO and WT mice were similar (Figure 6E). We found a higher level of PGC-1a protein, an important regulator of mitochondrial biogenesis, in KO mice and a similar level in TG mice compared with WT mice (Figure 6F). Thus, b-catenin affects mitochondrial biogenesis via a PGC-1aeindependent pathway.
The American Journal of Pathology
-
In HFD-fed KO mice, we found lower protein levels of hepatic fatty acid synthase, a key lipogenic enzyme, and GCK, an important hepatic glycolytic enzyme. In contrast, we found higher levels of both proteins in HFD-fed TG mice (Figure 7A). However, levels of the lipogenesis regulator PPAR-g were similar between the genotypes. Thus, b-catenin regulates HFD-induced hepatic glycolysis and lipogenesis independently of PPAR-g. We next determined by real-time PCR whether b-catenin regulates expression of important metabolic genes in the liver. To avoid the confounding effects of HFD-induced changes in adiposity and insulin signaling, we performed these assays using livers from chow-fed mice that were fasted overnight or fasted and then refed for 6 hours. Expression of most tested genes was similar between the mice (Figure 7B). However, KO mice failed to up-regulate Gck and Fasn (encoding fatty acid synthase) in the fed state, whereas TG mice had higher GCK expression in the fasting state. Unlike a previously published report, we found no difference in gluconeogenic gene expression between the WT and KO mice.14 GCK is a critical regulator of glycolysis and lipogenesis in the liver.17 Therefore, we focused on Gck. We found that the GCK protein was lower in chow-fed fasted and refed KO mice and higher in fed TG mice (Figure 7C). However, unlike our PCR results, we did not find higher GCK levels in fasted TG mice, a discrepancy that may be due to posttranscriptional regulation of Gck. We performed ChIP assay in the human hepatoma cell line Hep3B to determine whether Gck is a direct b-catenin target. We did not detect binding by b-catenin or its transcriptional coactivator TCF7L2 (also called TCF4), along the 2-kb liver-specific Gck promoter region (Figure 7D).
b-Catenin Disruption Affects the Zonal Oxygen Gradient and Levels of HIF-1a HIF-1a is an oxygen-sensitive transcriptional activator of Gck and glycolysis. Under hypoxic conditions, HIF-1a signaling in the liver depends on b-catenin.18 We found that hepatic HIF-1a protein levels were lower in HFD-fed KO and higher in TG mice compared with WT mice (Figure 8A). HIF-1a is subject to hypoxic regulation and rapidly degrades in nonhypoxic conditions. To determine whether loss of b-catenin affected the lobular oxygen gradient, we injected chow-fed KO and WT mice that were breathing room air (21% oxygen) with pimonidazole, a marker of tissue hypoxia. WT mice had perivenous staining for pimonidazole adducts. In contrast, KO animals had attenuated perivenous pimonidazole staining (Figure 8B). To determine whether the zonal pattern of pimonidazole staining was truly due to perivenous hypoxia or perivenous expression of enzymes affecting pimonidazole binding (eg, nitrosoreductases), we
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
9
1055 1056 1057 1058 1059 1060 1061 1062 ½F7 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 Q10 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 ½F8 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116
1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178
Behari et al
Figure 6 b-catenin regulates hepatic fatty acid oxidation, ketogenesis, and mitochondrial function. A: Palmitate oxidation rate in liver sections from overnight fasted, chow-fed mice. B: Serum b-hydroxybutyrate (BHB) levels from fasted (white bars) and refed (black bars) chow-fed mice. C: Citrate synthase activity in isolated mitochondria from freshly harvested livers of chow-fed wild-type (WT) and knockout (KO) mice. D: Relative hepatic mitochondrial DNA (mtDNA) content of chow- (white bars) and high-fat diet (HFD)efed mice at 4 weeks (gray bars) and 8 weeks (black bars). mtDNA content was determined as the ratio of the mitochondrial gene COXI and the nuclear gene 18S rRNA measured by real-time PCR. E: Western blot analysis for cytochrome c oxidase (COX) IV and peroxisome proliferator-activated receptor gamma coactivator (PGC)-1a in livers of WT, KO, and transgenic (TG) mice on chow or HFD. Tubulin is the loading control. Mice were fed the chow or HFD diets for 4 weeks and fasted for 4 hours before sacrifice for tissue collection at 11 AM. F: Quantification of Western blot results from E. Results are expressed as means SEM of four samples per group normalized to the internal loading control and expressed as relative value compared with the WT/chow group. n Z 5 per group (A and B), n Z 4 to 5 per group (D). *P < 0.05.
manipulated the inspired oxygen concentration to determine its affect on pattern of pimonidazole staining. WT and KO mice were exposed to intermittent hypoxia (30-second alternating cycles of 21% oxygen and 6% oxygen), continuous hypoxia (steady exposure to 10% oxygen) (Figure 8B), or room air (21% oxygen as control). Intermittent hypoxiaexposed WT mice had increased intensity and distribution of pimonidazole staining in a perivenous distribution compared with room airebreathing WT mice. On exposure to continuous hypoxia, WT mice had a bridging hypoxia pattern of pimonidazole staining, strongly supporting a model of lower sinusoidal oxygen concentration in the perivenous zone relative to the periportal zone. Under the two hypoxic conditions, KO mice had a subtle increase in pimonidazole staining compared with room airebreathing KO mice, but the intensity and distribution of pimonidazole staining were significantly less than in WT mice. We conclude that b-catenin is necessary for establishing the
10
normal sinusoidal oxygen gradient and likely regulates GCK expression via HIF-1a.
Discussion Our study provides several novel insights into the role of canonical Wnt signaling and metabolic zonation in liver and development of diet-induced obesity: i) b-catenin is necessary but not sufficient for the development of diet-induced fatty liver; ii) b-catenin regulates the zonal distribution of liver steatosis on the HFD; iii) b-cateninedependent changes in hepatic metabolic zonation profoundly affect systemic adiposity in the chronically overfed state; iv) b-catenin affects mitochondrial function and hepatic fatty acid oxidation and ketogenesis; and v) b-catenin regulates the sinusoidal oxygen gradient, one of the major determinants of liver metabolic function. Together, these complex effects of b-catenin link
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240
1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302
b-Catenin Links Hepatic Lipid Metabolism
Figure 7 b-catenin regulates expression of glycolytic and lipogenic genes in mice on the high-fat diet (HFD). A: Immunoblots for hepatic fatty acid synthase (FAS), glucokinase (GCK), and peroxisome proliferator-activated receptor (PPAR)-g from chow or HFD-fed wild-type (WT) and knockout (KO) mice (at 4 weeks) or WT and transgenic (TG) mice (at 8 weeks). B: Real-time PCR assays for steady-state mRNA levels of important metabolic genes as indicated: glycolysis (Gck and Pklr), lipogenesis (Fasn and Scd1), lipid droplet (Plin2), gluconeogenesis (Pck1 and G6pc), ketogenesis (Hmgcs2), fatty acid oxidation (Acadm and Acox1), and regulators (Hnf4a and Srebf1). Results are from chow-fed overnight fasted (white bars) and 6-hour refed (black bars) mice. C: Immunoblot for hepatic GCK from chow-fed fasted and refed mice. a-Tubulin was the internal loading control in A and C. D: Chromatin immunoprecipitation analysis in Hep3B cells for binding of transcription factor (TCF)-4 to the 2-kb liver-specific Gck promoter. SP5 is shown as positive and actin as negative controls. For fasting-refeeding experiments, mice were fasted overnight for 16 hours and refed for 6 hours starting at 7 AM. Fasted mice were sacrificed at 7 AM, and refed mice were sacrificed for tissue collection at 1 PM. n Z 5 per group (B). *P < 0.05.
metabolic zonation to the development of diet-induced fatty liver, obesity, and systemic insulin resistance. Our study contributes to the understanding of the functional significance of metabolic zonation of the mammalian liver.2,3 Our results indicate that disruption of metabolic zonation is dispensable in the unstressed liver. However, metabolic zonation is critical for the liver to respond to
The American Journal of Pathology
-
metabolic stress that results from starvation or chronic excess of energy intake. Thus, dynamic metabolic zonation is the key feature that confers the liver with its remarkable metabolic plasticity and allows the liver to closely integrate its metabolic responses with changes taking place in the rest of the body. KO mice experience the deleterious effects of chronic excess of energy intake in the absence of this
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
11
Q17
1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364
1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488
print & web 4C/FPO
1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426
Behari et al
12
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550
b-Catenin Links Hepatic Lipid Metabolism
Q11
hepatic metabolic plasticity. KO mice have defective fastingrelated functions (gluconeogenesis, ketogenesis, and fatty acid oxidation) and feeding-related functions (glycolysis and lipogenesis and weight gain on the HFD). Although KO mice exhibit resistance to diet-induced obesity, this occurs at the expense of increased hepatocyte apoptosis and inflammation. In contrast, TG mice have the opposite phenotype with an exaggerated response to HFD, characterized by striking liver steatosis, diet-induced obesity, and rapid development of systemic insulin resistance, likely related to the increased hepatic lipogenesis on the HFD. Thus, tight regulation of hepatic metabolic zonation appears to be a critical feature necessary for optimum metabolic adaptation to long-term overfeeding. Our results suggest that b-catenin exerts its complex metabolic effects in part via modulating the sinusoidal oxygen gradient. Mitochondria are the major consumers of oxygen in cells, and periportal oxidative phosphorylation has been proposed as one of the determinants of the sinusoidal oxygen gradient.19e21 Our results suggest that mitochondrial defects in KO livers not only affect periportal-predominant functions but also influence downstream perivenouspredominant functions, such as glycolysis and lipogenesis. Oxygen is a major regulator of hepatic metabolic zonation and carbohydrate metabolism.21 HIF-1a is the critical oxygen-sensing protein that regulates Gck and glycolytic genes.22,23 Liver-specific HIF-1a KO mice are protected from hepatic steatosis.24 We propose that amelioration of the perivenous hypoxia in KO mice down-regulates hepatic HIF1a and Gck expression (Figure 8C). Our findings support recent studies reporting that hypoxia promotes development of fatty liver via increased lipogenesis.25,26 Our results suggest that b-catenin indirectly regulates Gck expression. However, b-catenin has complex regulatory functions that are not fully understood. Therefore, we cannot exclude the possibility that b-catenin regulates Gck by binding to sites distal to its liver-specific promoter examined in our study. Canonical Wnt signaling regulates mitochondrial biogenesis in a myoblast cell line.16 Our results support a similar role of b-catenin in hepatocytes. Our findings add to
increasing evidence that supports a role for b-catenin in regulating hepatic mitochondrial oxidative phosphorylation.7,27,28 We did not find differences in gluconeogenic gene expression between WT and KO mice.14 Because KO mice exhibit mitochondrial dysfunction, we propose that these defects underlie the observed abnormalities in gluconeogenesis and ketogenesis in KO mice. In addition, the associated defects in fatty acid oxidation likely explain the severe steatosis observed in KO mice on the methionine cholineedeficient diet, which promotes mobilization of fatty acids to the liver but not increased lipogenesis.5 A surprising result of our study was that hepatocyte b-catenin regulates development of diet-induced obesity. There are several possible mechanisms for these effects: i) changes in hepatic lipogenesis after a meal may affect the delivery of very low-density lipoproteins from the liver to the rest of the body; ii) b-catenin regulates bile acid homeostasis, which may contribute to defective fat absorption and higher feces output on the HFD in KO mice8; iii) HFD-induced liver steatosis likely contributes to hepatic insulin resistance and affects energy balance throughout the body; iv) alterations in hepatic mitochondrial ketogenesis and gluconeogenesis during fasting influence metabolism in extrahepatic tissues; and v) KO mice have lower and TG mice have higher serum glutamine levels on chow and HFD diets. Glutamine plays a critical role in regulation of anabolic pathways, such as mTOR, and also regulates adipocyte function.29,30 Furthermore, b-catenin plays a critical role in hepatic ammonia detoxification, and KO mice exhibit increased serum ammonia levels on a highprotein diet. Thus, altered serum glutamine levels and changes in ammonia detoxification may be important links between b-cateninedependent hepatic metabolic function and systemic energy homeostasis. Further studies will be required to clarify the relative contributions of these dynamic and complex mechanisms on systemic metabolism. Understanding the zonal patterns of liver steatosis carries implications for elucidating the pathogenesis of NAFLD. The most common pattern of steatosis in NAFLD is perivenous.31 In contrast, predominantly periportal steatosis occurs in
The American Journal of Pathology, Vol. 184, No. 12, December 2014
ajp.amjpathol.org
b-Catenin Links Hepatic Metabolic Zonation with Lipid Metabolism and Diet-Induced Obesity in Mice Q18
Jaideep Behari,* Huanan Li,* Shiguang Liu,* Maja Stefanovic-Racic,y Laura Alonso,y Christopher P. O’Donnell,z Sruti Shiva,x Srikanth Singamsetty,z Yoshio Watanabe,z Vijay P. Singh,* and Qing Liu* From the Divisions of Gastroenterology, Hepatology, and Nutrition,* Endocrinology and Metabolism,y and Pulmonary and Critical Care Medicine,z Department of Medicine, and the Department of Pharmacology and Chemical Biology,x University of Pittsburgh, Pittsburgh, Pennsylvania Accepted for publication August 21, 2014. Address correspondence to Jaideep Behari, M.D., Ph.D., Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Ste. 916, Kaufmann Medical Bldg., 3471 Fifth Ave., Pittsburgh, PA 15213. E-mail: [email protected].
Q1
b-catenin regulates the establishment of hepatic metabolic zonation. To elucidate the functional significance of liver metabolic zonation in the chronically overfed state in vivo, we fed a high-fat diet (HFD) to hepatocyte-specific b-catenin transgenic (TG) and knockout (KO) mice. Chow-fed TG and KO mice had normal liver histologic findings and body weight. However, HFD-fed TG mice developed prominent perivenous steatosis with periportal sparing. In contrast, HFD-fed KO mice had increased lobular inflammation and hepatocyte apoptosis. HFD-fed TG mice rapidly developed diet-induced obesity and systemic insulin resistance, but KO mice were resistant to diet-induced obesity. However, b-catenin did not directly affect hepatic insulin signaling, suggesting that the metabolic effects of b-catenin occurred via a parallel pathway. Hepatic expression of key glycolytic and lipogenic genes was higher in HFD-fed TG and lower in KO mice compared with wild-type mice. KO mice also exhibited defective hepatic fatty acid oxidation and fasting ketogenesis. Hepatic levels of hypoxia inducible factor-1a, an oxygen-sensitive transcriptional regulator of glycolysis and a known b-catenin binding partner, were higher in HFD-fed TG and lower in KO mice. KO mice had attenuated perivenous hypoxia, suggesting disruption of the normal sinusoidal oxygen gradient, a major determinant of liver carbohydrate and liver metabolism. Canonical Wnt signaling in hepatocytes is essential for the development of diet-induced fatty liver and obesity. (Am J Pathol 2014, 184: 1e15; http://dx.doi.org/10.1016/j.ajpath.2014.08.022)
The liver exhibits remarkable metabolic plasticity that allows it to play a central role in systemic energy homeostasis. During periods of starvation, the liver is a major source of energy via hepatic glucose and ketone body production. In contrast, after feeding, the liver suppresses glucose production, takes up glucose, up-regulates lipogenesis, and helps to restore normoglycemia.1 Dysfunction of these normal physiologic processes plays a role in the pathogenesis of major metabolic disorders, such as obesity, diabetes mellitus, and nonalcoholic fatty liver disease (NAFLD). Thus, it is critical to elucidate the molecular pathways that regulate normal liver metabolic function. The mammalian liver exhibits metabolic zonation, which is characterized by the heterogeneous distribution of metabolic function across the hepatic lobule.2 Functions such as oxidative phosphorylation and gluconeogenesis predominate in the periportal (zone 1) region. In contrast, glycolysis, lipogenesis, and xenobiotic metabolism occur predominantly
in the perivenous (zone 3) region.2,3 Most metabolic functions exhibit dynamic zonation, depending on the prevailing nutritional state. In contrast, some functions (eg, expression of glutamine synthetase [GS] in a narrow rim of perivenous hepatocytes) exhibit fixed zonation that does not vary with the feeding cycle. b-catenin, the central player in the canonical Wnt signaling pathway, plays a critical role in establishing liver metabolic zonation. Targeted deletion of b-catenin in hepatocytes causes expansion of the periportal gene expression program and down-regulation of many perivenous genes. Conversely, constitutive activation of b-catenin expands the perivenous Supported in part by NIH grant 5K08AA017622 (J.B.). Disclosures: None declared. Current address of L.A., Division of Diabetes, Department of Medicine, University of Massachusetts Medical School, Worcester, MA; of V.P.S., Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ.
Copyright ª 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/j.ajpath.2014.08.022
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124
125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186
Behari et al gene expression program and down-regulates expression of periportal genes.4 Currently, we do not understand the precise role of metabolic zonation in liver and systemic carbohydrate and lipid metabolism in vivo. We used liver-specific b-catenin knockout (KO) and transgenic (TG) mice to determine the effect of manipulating liver metabolic zonation in the chronically overfed state. We found that by linking metabolic zonation with lipogenesis and systemic energy balance, b-catenin, plays a critical role in conferring metabolic plasticity to the liver.
Materials and Methods Animals and Dietary Treatments
Q2
Liver-specific b-catenin KO mice (Ctnnb1loxp/loxp;AlbuminCreþ/) in a C57Bl/6 background were generated as previously described.5 Littermates with wild-type Ctnnb1 allele were used as controls. Liver-specific b-catenin TG mice were a gift of Dr. Satdarshan Monga (University of Pittsburgh, Pittsburgh, PA) and were generated as previously described.6 TG mice express, under control of the hepatocyte-specific albumin promoter, b-catenin protein carrying a mutation (S45D) that makes it resistant to proteasomal degradation. TG mice were generated in a mixed background and backcrossed for six generations into the C57BL/6 background. Male mice between 8 and 12 weeks of age were used for all experiments. The animals were maintained under a 12hour dark/light cycle and had free access to food and water. An adjusted calorie high-fat diet (HFD; Harlan Teklad TD.88137, Harlan Laboratories, Indianapolis, IN; 4.5 kcal/ g with 15.2% kcal from protein, 42.7% kcal from carbohydrate, and 42% kcal from fat) or chow diet (Teklad Global Diet 2018, Harlan Laboratories; 3.1 kcal/g with 24% kcal from protein, 58% kcal from carbohydrate, and 18% kcal from fat) was used for 1 to 8 weeks as indicated in the results section. For experiments with HFD and chow-fed mice, animals were fasted for 4 hours before sacrifice. For fastingrefeeding experiments, chow-fed mice were fasted overnight (16 hours) and sacrificed at 7 AM or fasted overnight and then refed for exactly 6 hours and sacrificed at 1 PM. In all experiments and at each time point, the KO or TG mice were paired with corresponding wild-type (WT) animals to allow comparisons among genotypes. All animal experiments were performed with the approval of the University of Pittsburgh Institutional Animal Care and Use Committee and in accordance with NIH guidelines.
Serum and Liver Biochemical Assays Blood glucose was measured using an Ascencia XL Glucometer or a commercially available kit from Stanbio Laboratory (Boerne, TX; catalog no. 1070). Serum insulin was measured by radioimmunoassay (Linco sensitive rat insulin radioimmunoassay kit; Millipore, Billerica, MA). The serum
2
glutamine level was measured by quantitative colorimetric determination via a commercially available assay kit (BioAssay Systems, Hayward, CA; catalog no. EGLN-100). Serum b-hydroxybutyrate levels were measured using an automated analyzer by the University of Pittsburgh Medical Center Clinical Chemistry Laboratory. Serum and liver triglyceride and cholesterol assays were performed as previously described.7,8
Glucose Tolerance Test, Insulin Treatment, and Hyperinsulinemic-Euglycemic Clamp Studies Glucose tolerance test was performed in mice fasted for 16 hours followed by 1-g/kg intraperitoneal glucose injection. Blood glucose was measured from the tail vein at baseline and 15, 30, 60, and 90 minutes using a glucose meter. For treatment with insulin, mice maintained on chow diet were fasted overnight and injected with an i.p. bolus injection of insulin (2 U/kg). Mice were euthanized after 20 minutes and livers rapidly harvested and snap frozen in liquid nitrogen for further analysis. For insulin clamp studies, catheters were chronically implanted in the left femoral artery and vein for measurement of blood glucose and for infusion of insulin and radioisotope tracers. After a 48- to 72-hour recovery period after catheter placement, serum was collected from overnight-fasted mice for measurement of plasma insulin, free fatty acids, and glucose. Baseline hepatic glucose output was determined during a 120-minute period by infusing [3-3H]glucose (10mCi bolus þ 0.1 mCi/minute; NEN Life Science Products, Boston, MA) through the femoral vein using a microdialysis pump. A 100-mL sample of arterial blood was collected at 120 minutes for determination of plasma glucose, insulin, and [3-3H]glucose levels. After the basal period, a 2-hour hyperinsulinemic euglycemic clamp procedure was performed. Whole-body insulin sensitivity was determined by infusing a constant rate of human insulin and a variable rate of dextrose 50% glucose through the femoral venous catheter and maintaining plasma glucose at 100 to 125 mg/dL. Blood glucose levels were sampled from the femoral artery catheter at 10-minute intervals using a glucose meter. The mean glucose infusion rate during the last 30 minutes of the insulin clamp was used to determine insulin sensitivity.
Histologic and IHC Evaluation of the Liver Formalin-fixed, paraffin-embedded liver sections were stained with hematoxylin and eosin (H&E) or Oil Red O as previously described.5 Liver sections were stained with b-catenin (1:200), cytochrome P450 (Cyp) 2E1 (1:100), and GS (1:100) antibodies from Abcam (Cambridge, MA) using standard immunohistochemical (IHC) techniques. Staining for apoptotic cells by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) method was performed using the ApopTag Peroxidase Kit (Millipore; catalog no. S7100). Liver cryosections were stained for glucokinase (GCK; 1:50; Santa
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248
249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310
b-Catenin Links Hepatic Lipid Metabolism Cruz Biotechnology, Santa Cruz, CA) and immunofluorescence microscopy performed as previously described.7
Gene Expression Analysis by Protein Immunoblotting and Real-Time PCR
Q3
Crude liver extracts were prepared as previously described.8 Immunoblotting was performed using the following primary antibodies: b-catenin (BD Biosciences and Cell Signaling, San Jose, CA), glyceraldehyde-3-phosphate dehydrogenase (Abcam), fatty acid synthase (Santa Cruz Biotechnology), GCK (Santa Cruz Biotechnology), hypoxia inducible factor (HIF)-1a (Novus Biologicals, Littleton, CO), phosphor-Akt (Ser473), phosphor-Akt (Thr308), pan-Akt, phosho-S6, S6, phosphor-GSK-3b (Ser9), and GSK-3b (all from Cell Signaling), peroxisome proliferator-activated receptor (PPAR)-g (Santa Cruz), a-tubulin (Abcam), cytochrome c oxidase (COX) IV antibody (Cell Signaling), and peroxisome proliferator-activated receptor gamma coactivator (PGC)-1a (Novus Biologicals). Western blots were quantified using densitometric analysis using the ImageJ version 1.44 (NIH, Bethesda, MD).9 Results from two experiments, each with two samples per group, were averaged and normalized to the corresponding loading control. Real-time PCR was performed using proprietary Taqman primers (Applied Biosystems, Carlsbad, CA) as previously described.8
Metabolic Cage Experiment
Q4
The respiratory exchange ratio, activity, and stool output were measured in an Oxymax Comprehensive Laboratory Animal Monitoring System (Columbus Instruments, Columbus, OH) with 1 mouse per chamber. WT and KO mice were allowed ad libitum access to the HFD for 1 week before the experiment. On day 7, mice were weighed and placed in the chamber at 10 AM and allowed to acclimate for 4 hours. Measurements for oxygen consumption, carbon dioxide consumption, and activity were recorded on a computer every 10 minutes for the next 20 hours at room temperature. The animals had free access to food and water during the experiment. The respiratory exchange ratio was measured as carbon dioxide consumption/ oxygen consumption, and activity was calculated as the sum of x þ z (ambulatory and vertical movements, respectively) scores. Food intake and stool output were measured at the end of the experiment.
ChIP Assay
Q5
Chromatin immunoprecipitation (ChIP) assays were performed using the Millipore ChIP assay kit (catalog no. 17-295) as previously described.7 The human hepatoma cell line Hep3B and transcription factor (TCF)-4 antibody (Millipore; catalog no. 17-10109) were used for the ChIP assay. Positive control primers for the SP5 promoter were as follows: 50 -GGGTCTCCAGGCGGCAAG-30 (forward primer) and 50 -AGCGAAAGCAAATCCTTTGAATCC-30 (reverse primer). Scanning
The American Journal of Pathology
-
ChIP primers were designed at 300- to 400-bp intervals along the liver-specific human Gck promoter. The primers spanned a region from 3000 to þ200 bp relative to the liver-specific transcription start of the Gck promoter. An unrelated promoter (b-actin) was used as the negative control. Scanning primer sequences are available on request.
Hypoxia Studies and Pimonidazole Staining for Tissue Hypoxia Mice were placed in regular cages customized to deliver varying concentrations of inspired oxygen. A gas control delivery system regulated the flow of oxygen, nitrogen, and room air into the customized cages, and a series of flow regulators allowed the manipulation of inspired oxygen.10 In the intermittent hypoxia group, oxygen levels decreased from 21% to 6% for a 30-second period followed by quick reoxygenation to room air levels via a burst of 100% oxygen (60 cycles hour1). A second set of mice was exposed to continuous hypoxia in the customized cages during which the oxygen concentration was maintained at 10%. Control animals (sham treated) were housed in the same customized cages at the same time as the treated animals but only exposed to room air (21% oxygen). The Hypoxyprobe-1 Omni kit (HPI Inc., Burlington, MA) was used for the detection of tissue hypoxia. Pimonidazole hydrochloride was administered by i.p. injection at a dosage of 60 mg/kg. Liver tissue was collected after 60 minutes. Pimonidazole is reductively activated in hypoxic cells, and the activated intermediate forms stable covalent adducts with proteins.11 IHC for protein adducts of pimonidazole was performed with PAb2627AP, an affinity purified rabbit antibody as per the manufacturer’s recommendations (HPI Inc.).
Determination of Mitochondrial Biogenesis Mitochondrial DNA copy number was determined using a modification of a previously described approach.12 Total DNA was prepared from liver tissue using DNeasy spin columns and DNA concentration measured spectrophotometrically. The quantity of mitochondrial-encoded COX1 relative to the nuclear-encoded gene 18S rRNA was measured using TaqMan real-time using proprietary primers (Applied Biosystems; Mm04225243_g1). Mitochondrial aerobic capacity was measured by assaying for the activity of the mitochondrial matrix enzyme citrate synthase activity as previously described.7
Palmitate Oxidation Assays Fatty acid oxidation was determined ex vivo in freshly harvested livers as previously described.13 Liver sections were weighed (approximately 200 mg per well) and incubated in Dulbecco’s modified Eagle’s medium/10% fetal Q6
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
3
311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372
373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 ½F1 396 397 398 Q7 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 ½F2 425 426 427 428 429 430 431 432 433 434
Behari et al bovine serum in the presence of 0.1 mmol/L palmitate and [3H]-palmitate (20 mCi per well) at 37 C for 2 hours in duplicate wells for each animal. Tritiated water was determined in the collected medium by a vapor-phase equilibration method.
Statistical Analysis Results were analyzed by Student’s t-test for comparison between the two groups and by one-way analysis of variance when more than two groups were compared. P < 0.05 was considered significant.
Results Hepatic b-Catenin Determines Zonal Patterns of Liver Steatosis on the HFD On chow diet, TG mice exhibited grossly normal liver but 8% higher liver/body ratio compared with WT mice, as previously described (Figure 1, A and B).6 TG mice also had normal serum biochemical assay results (data not shown). On histologic examination, neither group of mice exhibited liver steatosis on chow diet. However, at 8 weeks on the HFD, TG mice exhibited grossly larger and steatotic livers but similar liver/body ratio to WT mice (Figure 1, A and B). On H&E staining, HFD-fed TG mice had a striking increase in hepatic steatosis in perivenous and midzonal hepatocytes. In contrast to the lipid-laden perivenous hepatocytes, we observed almost no steatosis in periportal hepatocytes in HFD-fed TG mice (Figure 1C). Oil Red O staining revealed a higher amount of neutral lipid in hepatocytes from HFD-fed TG mice (Figure 1C). Hepatocytes in HFD-fed TG mice were larger than in HFD-fed WT mice and engorged with microvesicular and macrovesicular steatosis (Figure 1D). HFD-fed TG mice had threefold higher liver triglyceride levels but similar total cholesterol levels compared with WT mice (Figure 1E). We treated another set of WT and TG mice with chow and HFD for 4 weeks. TG mice fed the HFD for 4 weeks had a phenotype similar to that at 8 weeks, except that weight gain (data not shown) and degree of perivenous steatosis (Supplemental Figure S1) were less striking at 4 weeks than at 8 weeks. KO mice had similar histologic appearance to WT mice on chow diet. However, at 4 weeks, HFD-fed KO mice had more prominent periportal steatosis with relative perivenous sparing (Figure 2A). HFD-fed KO mice also exhibited increased lobular inflammation (Figure 2B). However, WT and KO mice exhibited similar gross appearance of the liver on the HFD (Figure 2C). HFD-fed KO mice had lower hepatic triglyceride levels but similar total cholesterol levels compared with WT mice (Figure 2D). TUNEL staining revealed multiple apoptotic cells in livers from HFD-fed KO mice (Figure 2E and Supplemental Figure S2), and Western blot analysis revealed higher
4
activated caspase 3 levels in livers of HFD-fed KO mice (Figure 2F and Supplemental Figure S3). Thus, KO mice exhibited lower hepatic triglyceride accumulation but higher HFD-induced hepatocyte toxic effects. In HFD-fed TG mice, we found no difference in TUNEL staining or activated caspase 3 level in the liver relative to HFD-fed WT mice (data not shown).
Effect of HFD on b-Catenin and Zonal Expression Patterns of Its Target Genes As expected, hepatocytes were negative for b-catenin staining in KO mice. However, HFD-fed TG mice frequently had cytoplasmic and nuclear staining for b-catenin in hepatocytes (Figure 3 and Supplemental Figure S4). ½F3 Two well-established b-catenin target genes, Cyp2E1 and GS, exhibit differential perivenous expression patterns. Cyp2E1 exhibits dynamic zonation, whereas GS exhibits fixed zonation in a narrow rim of perivenous hepatocytes. We found increased intensity of Cyp2E1 staining and expansion of the perivenous zone of expression in HFD-fed WT mice (Figure 3). We observed no hepatic Cyp2E1 staining in KO mice. In chow-fed TG mice, we found that a wider zone of perivenous hepatocytes stained positive for Cyp2E1. In HFDfed TG mice, Cyp2E1 expression expanded to the midzonal region and strongly correlated with steatosis within hepatocytes (Figure 3). In contrast to Cyp2E1, we found no difference between chow- and HFD-fed WT mice in the zonal pattern of expression of GS. KO mice did not express GS in the liver. TG mice exhibited more intense GS staining but in a zonal expression pattern that was similar to that in WT mice (Figure 3). Consistent with the changes in hepatic GS expression, KO mice exhibited lower and TG mice higher serum glutamine levels on chow and HFD diets compared with WT mice (Supplemental Q8 Figure S5).
Hepatic b-Catenin Modulates Development of Diet-Induced Obesity On chow diet, WT and TG mice had similar weight and were morphologically indistinguishable. However, HFD-fed TG mice gained more weight and at 8 weeks exhibited prominent visceral fat and higher perigonadal fat pad mass compared with WT mice (Figure 4A). On chow diet, KO mice had body ½F4 weight and visceral fat similar to WT mice. However, HFDfed KO mice gained less weight and exhibited less prominent visceral fat and lower perigonadal fat pad mass at 4 weeks compared with WT mice (Figure 4B and Supplemental Figure S6). We next performed metabolic cage experiments with mice fed the HFD for 1 week to acclimatize them to the diet but avoid potential compensatory changes. Compared with WT mice, HFD-fed KO mice exhibited overall higher and TG mice lower respiratory exchange ratio (3%, P < 0.01) (Figure 4C). The three genotypes had similar activity levels
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496
and normal circadian variation in activity (Figure 4D). Food intake was similar between the mice (Figure 4E). HFD-fed KO mice but not TG mice had twofold higher stool mass, suggesting defects in intestinal fat absorption
Q9
(Figure 4F). To ensure that these systemic effects resulted from hepatic b-catenin disruption, we confirmed that bcatenin expression was intact in extrahepatic tissues (Figure 4G).
print & web 4C=FPO
497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558
b-Catenin Links Hepatic Lipid Metabolism
Figure 1 High-fat diet (HFD)efed transgenic (TG) mice have a predominantly perivenous pattern of liver steatosis. Mice were fed the HFD or chow diets for 8 weeks. For tissue collection, mice were fasted for 4 hours from 7 AM and sacrificed at 11 AM. A: Gross appearance of the liver from chow and HFD-fed TG and wild-type (WT) mice. B: Liver/body weight ratio. C: Liver sections stained with hematoxylin-eosin and Oil Red O. Note the strongly perivenous pattern of steatosis with periportal sparing in TG/HFD livers. D: Magnified view of hepatocytes from HFD-fed WT and TG liver. E: Liver triglyceride and total cholesterol levels. Data are expressed as means SEM of five mice per group (chow) and seven mice per group (HFD). *P < 0.05, **P < 0.01. Scale bar Z 100 mm (C). Original magnification: 100 (C, top row); 200 (C, remaining rows, and D). C, central vein; P, portal area.
The American Journal of Pathology
-
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
5
559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 Q12 Q13 615 616 617 618 619 620
b-Catenin Does Not Directly Affect Hepatic Insulin Signaling Random and fasting serum glucose levels were similar in HFD-fed WT and TG mice. In contrast, HFD-fed TG mice
exhibited higher fasting serum insulin levels (Figure 5A). ½F5 TG mice also exhibited impaired glucose tolerance on the HFD but not chow diet (Figure 5B). Similar to previously published results, KO mice exhibited improved insulin sensitivity on both chow and HFD (data not shown).14
print & web 4C=FPO
621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682
Behari et al
Figure 2
High-fat diet (HFD)efed knockout (KO) mice exhibit periportal steatosis, lobular inflammation, and hepatocyte apoptosis. Mice were fed the HFD or chow diets for 4 weeks. Mice were fasted for 4 hours from 7 AM and sacrificed at 11 AM for tissue collection. A: Hematoxylin and eosin (H&E)estained liver sections from chow- or HFD-fed wild-type (WT) and KO mice. B: Low power view of H&E-stained liver sections. Note the foci of inflammatory cells in HFD-fed KO liver. C: Gross liver morphologic findings in mice on chow and HFD diets and quantitation of liver/body ratio. D: Liver triglyceride and total cholesterol levels at 4 weeks. Data are presented as means SEM of five mice per group. E: Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining reveals apoptotic cells in livers from HFD-fed KO mice (black arrowheads). F: Western blot analysis for activated caspase 3 (longer exposure emphasizes differences in C3 expression). Glyceraldehyde-3-phosphate dehydrogenase is the internal loading control (shorter exposure). Scale bar Z 100 mm (A and B). Original magnification: 200 (A); 100 (B); 400 (E). *P < 0.05. Neg, negative control; Pos, positive control (spleen sections).
6
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
Q14
683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744
print & web 4C=FPO
745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806
b-Catenin Links Hepatic Lipid Metabolism
Figure 3 Zonal expression patterns of b-catenin and its target genes on mice fed the high-fat diet (HFD). Mice were fed the HFD or chow diets for 4 weeks. For tissue collection, mice were fasted for 4 hours from 7 AM and sacrificed at 11 AM. A: Liver sections from chow- or HFD-fed knockout (KO), wild-type (WT), and transgenic (TG) mice stained with b-catenin, Cyp2E1, or GS as indicated. Hepatocytes with cytoplasmic and nuclear b-catenin staining on the HFD are marked with white arrowheads. Note the absence of Cyp2E1 and GS staining in KO mice and the perivenous zonal pattern of expression of both genes in WT and TG mice. Also note the correlation between Cyp2E1 staining and hepatocyte steatosis in HFD-fed TG mice.
We next performed hyperinsulinemic-euglycemic clamp studies on long-term catheterized conscious mice to determine the mechanism of HFD-induced insulin resistance. Chow-fed TG and WT mice had similar insulin sensitivity and hepatic glucose production (Figure 5, C and D). These results suggest that insulin resistance in HFD-fed TG mice
The American Journal of Pathology
-
was the result of increased adiposity and fatty liver and not the mutant b-catenin allele per se. To determine the effect of b-catenin on insulin signaling, we treated chow-fed, overnight fasted WT, KO, and TG mice with insulin. In the fasting state or after insulin treatment, we found similar phosphorylation patterns of proteins (Akt, GSK-3b, and
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
7
Q15 Q19
807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868
print & web 4C=FPO
869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930
Behari et al
Hepatic b-catenin regulates systemic energy homeostasis. A: Body weight change, morphologic findings, and perigonadal fat pads from chowand high-fat diet (HFD)efed transgenic (TG) and wild-type (WT) mice. Mice were fed chow or HFD for 8 weeks and fasted for 4 hours before sacrifice for tissue collection at 11 AM. B: Body weight change, morphologic findings, and perigonadal fat pads from chow and HFD-fed WT and knockout (KO) mice. Mice were fed chow or HFD for 4 weeks and fasted for 4 hours before sacrifice for tissue collection at 11 AM. C: Respiratory exchange ratio on the HFD. D: Activity level on the HFD expressed as the total of X (horizontal) and Z (vertical) movements measured in the metabolic cage. E: Food intake in HFD-fed WT, TG, and KO mice measured during the metabolic cage experiment. F: Feces dry weight on the HFD during 24 hours. G: Protein immunoblot analysis for b-catenin using lysates prepared from various organs from WT and KO mice. Glyceraldehyde-3-phosphate dehydrogenase was used as a loading control. n Z 5 to 8 per group (A); n Z 5 to 7 per group (B); n Z 5 per group (CeF). *P < 0.05 (AeD and F). Pancr, pancreas; VAT, visceral adipose tissue; Vastus, vastus muscle.
Figure 4
S6) in the insulin-signaling pathway (Figure 5E). We conclude that b-catenin does not directly affect hepatic insulin signaling.
b-Catenin Regulates Hepatic Fatty Acid Oxidation, Ketogenesis, and Mitochondrial Function In the fasting state, both mitochondrial fatty acid oxidation and ketogenesis predominate in periportal hepatocytes.15
8
We hypothesized that an underlying mitochondrial defect contributes to periportal steatosis in HFD-fed KO mice. We found that chow-fed KO mice had lower hepatic palmitate oxidation rate ex vivo (Figure 6A). Chow-fed ½F6 fasted KO mice also exhibited lower serum levels of the ketone body b-hydroxybutyrate, suggesting defective fasting ketogenesis (Figure 6B). We also found lower mitochondrial activity of citrate synthase, the rate-limiting
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992
993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054
b-Catenin Links Hepatic Lipid Metabolism
b-Catenin Regulates Expression of Glycolytic and Lipogenic Genes on the HFD
b-catenin indirectly regulates hepatic insulin signaling. A: Fasting or random serum glucose from high-fat diet (HFD)efed wild-type (WT) and transgenic (TG) mice and serum insulin levels from chow or HFD-fed WT and TG mice collected after 4 hours of fasting. B: I.P. glucose tolerance tests (GTTs) in chow and HFD-fed WT and TG mice. C: Hyperinsulinemic-euglycemic clamp studies with chow-fed WT and TG mice revealing glucose infusion rate, blood glucose levels during the clamp, and hepatic glucose production. D: Hepatic glucose output measured during the insulin clamp study. E: Western blot analysis for proteins in the insulin-signaling pathway. Chow-fed, 16-hour overnight fasted mice were injected i.p. with saline (minus sign) or insulin (plus sign) and livers were harvested after 20 minutes. n Z 4 to 5 per group (A), n Z 5 per group (BeD). *P < 0.05, ***P < 0.001.
Figure 5
Q16
step in the tricarboxylic acid cycle, in fasted chow-fed KO mice (Figure 6C). Thus, KO mice have defective mitochondrial function in the liver. Wnt signaling regulates mitochondrial biogenesis.16 Therefore, we asked whether changes in b-catenin affected hepatic mitochondrial biogenesis. Mitochondrial DNA content, as measured by the relative DNA amounts of mitochondrialencoded COXI and nuclear-encoded 18S rRNA, was lower in HFD-fed KO and higher in TG mice at 4 weeks (Figure 6D). Immunoblot for COXIV protein revealed higher levels of the protein in chow and HFD-TG mice compared with WT animals, although levels between KO and WT mice were similar (Figure 6E). We found a higher level of PGC-1a protein, an important regulator of mitochondrial biogenesis, in KO mice and a similar level in TG mice compared with WT mice (Figure 6F). Thus, b-catenin affects mitochondrial biogenesis via a PGC-1aeindependent pathway.
The American Journal of Pathology
-
In HFD-fed KO mice, we found lower protein levels of hepatic fatty acid synthase, a key lipogenic enzyme, and GCK, an important hepatic glycolytic enzyme. In contrast, we found higher levels of both proteins in HFD-fed TG mice (Figure 7A). However, levels of the lipogenesis regulator PPAR-g were similar between the genotypes. Thus, b-catenin regulates HFD-induced hepatic glycolysis and lipogenesis independently of PPAR-g. We next determined by real-time PCR whether b-catenin regulates expression of important metabolic genes in the liver. To avoid the confounding effects of HFD-induced changes in adiposity and insulin signaling, we performed these assays using livers from chow-fed mice that were fasted overnight or fasted and then refed for 6 hours. Expression of most tested genes was similar between the mice (Figure 7B). However, KO mice failed to up-regulate Gck and Fasn (encoding fatty acid synthase) in the fed state, whereas TG mice had higher GCK expression in the fasting state. Unlike a previously published report, we found no difference in gluconeogenic gene expression between the WT and KO mice.14 GCK is a critical regulator of glycolysis and lipogenesis in the liver.17 Therefore, we focused on Gck. We found that the GCK protein was lower in chow-fed fasted and refed KO mice and higher in fed TG mice (Figure 7C). However, unlike our PCR results, we did not find higher GCK levels in fasted TG mice, a discrepancy that may be due to posttranscriptional regulation of Gck. We performed ChIP assay in the human hepatoma cell line Hep3B to determine whether Gck is a direct b-catenin target. We did not detect binding by b-catenin or its transcriptional coactivator TCF7L2 (also called TCF4), along the 2-kb liver-specific Gck promoter region (Figure 7D).
b-Catenin Disruption Affects the Zonal Oxygen Gradient and Levels of HIF-1a HIF-1a is an oxygen-sensitive transcriptional activator of Gck and glycolysis. Under hypoxic conditions, HIF-1a signaling in the liver depends on b-catenin.18 We found that hepatic HIF-1a protein levels were lower in HFD-fed KO and higher in TG mice compared with WT mice (Figure 8A). HIF-1a is subject to hypoxic regulation and rapidly degrades in nonhypoxic conditions. To determine whether loss of b-catenin affected the lobular oxygen gradient, we injected chow-fed KO and WT mice that were breathing room air (21% oxygen) with pimonidazole, a marker of tissue hypoxia. WT mice had perivenous staining for pimonidazole adducts. In contrast, KO animals had attenuated perivenous pimonidazole staining (Figure 8B). To determine whether the zonal pattern of pimonidazole staining was truly due to perivenous hypoxia or perivenous expression of enzymes affecting pimonidazole binding (eg, nitrosoreductases), we
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
9
1055 1056 1057 1058 1059 1060 1061 1062 ½F7 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 Q10 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 ½F8 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116
1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178
Behari et al
Figure 6 b-catenin regulates hepatic fatty acid oxidation, ketogenesis, and mitochondrial function. A: Palmitate oxidation rate in liver sections from overnight fasted, chow-fed mice. B: Serum b-hydroxybutyrate (BHB) levels from fasted (white bars) and refed (black bars) chow-fed mice. C: Citrate synthase activity in isolated mitochondria from freshly harvested livers of chow-fed wild-type (WT) and knockout (KO) mice. D: Relative hepatic mitochondrial DNA (mtDNA) content of chow- (white bars) and high-fat diet (HFD)efed mice at 4 weeks (gray bars) and 8 weeks (black bars). mtDNA content was determined as the ratio of the mitochondrial gene COXI and the nuclear gene 18S rRNA measured by real-time PCR. E: Western blot analysis for cytochrome c oxidase (COX) IV and peroxisome proliferator-activated receptor gamma coactivator (PGC)-1a in livers of WT, KO, and transgenic (TG) mice on chow or HFD. Tubulin is the loading control. Mice were fed the chow or HFD diets for 4 weeks and fasted for 4 hours before sacrifice for tissue collection at 11 AM. F: Quantification of Western blot results from E. Results are expressed as means SEM of four samples per group normalized to the internal loading control and expressed as relative value compared with the WT/chow group. n Z 5 per group (A and B), n Z 4 to 5 per group (D). *P < 0.05.
manipulated the inspired oxygen concentration to determine its affect on pattern of pimonidazole staining. WT and KO mice were exposed to intermittent hypoxia (30-second alternating cycles of 21% oxygen and 6% oxygen), continuous hypoxia (steady exposure to 10% oxygen) (Figure 8B), or room air (21% oxygen as control). Intermittent hypoxiaexposed WT mice had increased intensity and distribution of pimonidazole staining in a perivenous distribution compared with room airebreathing WT mice. On exposure to continuous hypoxia, WT mice had a bridging hypoxia pattern of pimonidazole staining, strongly supporting a model of lower sinusoidal oxygen concentration in the perivenous zone relative to the periportal zone. Under the two hypoxic conditions, KO mice had a subtle increase in pimonidazole staining compared with room airebreathing KO mice, but the intensity and distribution of pimonidazole staining were significantly less than in WT mice. We conclude that b-catenin is necessary for establishing the
10
normal sinusoidal oxygen gradient and likely regulates GCK expression via HIF-1a.
Discussion Our study provides several novel insights into the role of canonical Wnt signaling and metabolic zonation in liver and development of diet-induced obesity: i) b-catenin is necessary but not sufficient for the development of diet-induced fatty liver; ii) b-catenin regulates the zonal distribution of liver steatosis on the HFD; iii) b-cateninedependent changes in hepatic metabolic zonation profoundly affect systemic adiposity in the chronically overfed state; iv) b-catenin affects mitochondrial function and hepatic fatty acid oxidation and ketogenesis; and v) b-catenin regulates the sinusoidal oxygen gradient, one of the major determinants of liver metabolic function. Together, these complex effects of b-catenin link
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240
1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302
b-Catenin Links Hepatic Lipid Metabolism
Figure 7 b-catenin regulates expression of glycolytic and lipogenic genes in mice on the high-fat diet (HFD). A: Immunoblots for hepatic fatty acid synthase (FAS), glucokinase (GCK), and peroxisome proliferator-activated receptor (PPAR)-g from chow or HFD-fed wild-type (WT) and knockout (KO) mice (at 4 weeks) or WT and transgenic (TG) mice (at 8 weeks). B: Real-time PCR assays for steady-state mRNA levels of important metabolic genes as indicated: glycolysis (Gck and Pklr), lipogenesis (Fasn and Scd1), lipid droplet (Plin2), gluconeogenesis (Pck1 and G6pc), ketogenesis (Hmgcs2), fatty acid oxidation (Acadm and Acox1), and regulators (Hnf4a and Srebf1). Results are from chow-fed overnight fasted (white bars) and 6-hour refed (black bars) mice. C: Immunoblot for hepatic GCK from chow-fed fasted and refed mice. a-Tubulin was the internal loading control in A and C. D: Chromatin immunoprecipitation analysis in Hep3B cells for binding of transcription factor (TCF)-4 to the 2-kb liver-specific Gck promoter. SP5 is shown as positive and actin as negative controls. For fasting-refeeding experiments, mice were fasted overnight for 16 hours and refed for 6 hours starting at 7 AM. Fasted mice were sacrificed at 7 AM, and refed mice were sacrificed for tissue collection at 1 PM. n Z 5 per group (B). *P < 0.05.
metabolic zonation to the development of diet-induced fatty liver, obesity, and systemic insulin resistance. Our study contributes to the understanding of the functional significance of metabolic zonation of the mammalian liver.2,3 Our results indicate that disruption of metabolic zonation is dispensable in the unstressed liver. However, metabolic zonation is critical for the liver to respond to
The American Journal of Pathology
-
metabolic stress that results from starvation or chronic excess of energy intake. Thus, dynamic metabolic zonation is the key feature that confers the liver with its remarkable metabolic plasticity and allows the liver to closely integrate its metabolic responses with changes taking place in the rest of the body. KO mice experience the deleterious effects of chronic excess of energy intake in the absence of this
ajp.amjpathol.org
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
11
Q17
1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364
1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488
print & web 4C/FPO
1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426
Behari et al
12
ajp.amjpathol.org
-
The American Journal of Pathology
FLA 5.2.0 DTD AJPA1851_proof 10 October 2014 10:54 am EO: AJP13_0207
1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550
b-Catenin Links Hepatic Lipid Metabolism
Q11
hepatic metabolic plasticity. KO mice have defective fastingrelated functions (gluconeogenesis, ketogenesis, and fatty acid oxidation) and feeding-related functions (glycolysis and lipogenesis and weight gain on the HFD). Although KO mice exhibit resistance to diet-induced obesity, this occurs at the expense of increased hepatocyte apoptosis and inflammation. In contrast, TG mice have the opposite phenotype with an exaggerated response to HFD, characterized by striking liver steatosis, diet-induced obesity, and rapid development of systemic insulin resistance, likely related to the increased hepatic lipogenesis on the HFD. Thus, tight regulation of hepatic metabolic zonation appears to be a critical feature necessary for optimum metabolic adaptation to long-term overfeeding. Our results suggest that b-catenin exerts its complex metabolic effects in part via modulating the sinusoidal oxygen gradient. Mitochondria are the major consumers of oxygen in cells, and periportal oxidative phosphorylation has been proposed as one of the determinants of the sinusoidal oxygen gradient.19e21 Our results suggest that mitochondrial defects in KO livers not only affect periportal-predominant functions but also influence downstream perivenouspredominant functions, such as glycolysis and lipogenesis. Oxygen is a major regulator of hepatic metabolic zonation and carbohydrate metabolism.21 HIF-1a is the critical oxygen-sensing protein that regulates Gck and glycolytic genes.22,23 Liver-specific HIF-1a KO mice are protected from hepatic steatosis.24 We propose that amelioration of the perivenous hypoxia in KO mice down-regulates hepatic HIF1a and Gck expression (Figure 8C). Our findings support recent studies reporting that hypoxia promotes development of fatty liver via increased lipogenesis.25,26 Our results suggest that b-catenin indirectly regulates Gck expression. However, b-catenin has complex regulatory functions that are not fully understood. Therefore, we cannot exclude the possibility that b-catenin regulates Gck by binding to sites distal to its liver-specific promoter examined in our study. Canonical Wnt signaling regulates mitochondrial biogenesis in a myoblast cell line.16 Our results support a similar role of b-catenin in hepatocytes. Our findings add to
increasing evidence that supports a role for b-catenin in regulating hepatic mitochondrial oxidative phosphorylation.7,27,28 We did not find differences in gluconeogenic gene expression between WT and KO mice.14 Because KO mice exhibit mitochondrial dysfunction, we propose that these defects underlie the observed abnormalities in gluconeogenesis and ketogenesis in KO mice. In addition, the associated defects in fatty acid oxidation likely explain the severe steatosis observed in KO mice on the methionine cholineedeficient diet, which promotes mobilization of fatty acids to the liver but not increased lipogenesis.5 A surprising result of our study was that hepatocyte b-catenin regulates development of diet-induced obesity. There are several possible mechanisms for these effects: i) changes in hepatic lipogenesis after a meal may affect the delivery of very low-density lipoproteins from the liver to the rest of the body; ii) b-catenin regulates bile acid homeostasis, which may contribute to defective fat absorption and higher feces output on the HFD in KO mice8; iii) HFD-induced liver steatosis likely contributes to hepatic insulin resistance and affects energy balance throughout the body; iv) alterations in hepatic mitochondrial ketogenesis and gluconeogenesis during fasting influence metabolism in extrahepatic tissues; and v) KO mice have lower and TG mice have higher serum glutamine levels on chow and HFD diets. Glutamine plays a critical role in regulation of anabolic pathways, such as mTOR, and also regulates adipocyte function.29,30 Furthermore, b-catenin plays a critical role in hepatic ammonia detoxification, and KO mice exhibit increased serum ammonia levels on a highprotein diet. Thus, altered serum glutamine levels and changes in ammonia detoxification may be important links between b-cateninedependent hepatic metabolic function and systemic energy homeostasis. Further studies will be required to clarify the relative contributions of these dynamic and complex mechanisms on systemic metabolism. Understanding the zonal patterns of liver steatosis carries implications for elucidating the pathogenesis of NAFLD. The most common pattern of steatosis in NAFLD is perivenous.31 In contrast, predominantly periportal steatosis occurs in
